52867-42-2

Basic information

• Product Name: METHYL 3-HYDROXY-1-METHYLPYRAZOLE-5-CARBOXYLATE
• Synonyms: Methyl 2-methyl-5-oxo-2,5-dihydro-1H-pyrazole-3-carboxylate;2,5-Dihydro-2-methyl-5-oxo-1H-pyrazole-3-carboxylic acid methyl ester;Methyl 3-Hydroxy-1-Methyl-1H-Pyrazole-5-Carboxylate;METHYL 3-HYDROXY-1-METHYLPYRAZOLE-5-CARBOXYLATE;Methyl 3-hydroxy-1-Methylpyrazole;Methyl 3-hydroxy-1-Methyl-1H-pyrazole-4-carboxylate;1H-Pyrazole-3-carboxylic acid, 2,5-dihydro-2-Methyl-5-oxo-, Methyl ester;Methyl 3-Hydroxy-1-Methyl-1H-Pyrazole-5-Carboxylate(WXC00843)
• CAS NO: 52867-42-2
• Molecular Formula: C₆H₈N₂O₃
• Molecular Weight: 156.14
• Mol File: 52867-42-2.mol
• Article Data: 15

Chemical Properties

• Melting Point: 197 °C(Solv: methanol (67-56-1))
• Boiling Point: 330.7°Cat760mmHg
• Flash Point: 153.8°C
• Appearance: /
• Density: 1.288g/cm³
• Vapor Pressure: 8.48E-05mmHg at 25°C
• Refractive Index: 1.508
• Storage Temp.: 2-8°C
• PKA: 7.68±0.70(Predicted)
• CAS DataBase Reference: METHYL 3-HYDROXY-1-METHYLPYRAZOLE-5-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3-HYDROXY-1-METHYLPYRAZOLE-5-CARBOXYLATE(52867-42-2)
• EPA Substance Registry System: METHYL 3-HYDROXY-1-METHYLPYRAZOLE-5-CARBOXYLATE(52867-42-2)

Safety Data

• Hazardous Substances Data: 52867-42-2(Hazardous Substances Data)

Usage

General Description

Methyl 3-hydroxy-1-methylpyrazole-5-carboxylate is a chemical compound with the molecular formula C7H10N2O3. It is a derivative of Pyrazole, which is a five-membered heterocyclic compound containing a nitrogen atom. This chemical has applications in the pharmaceutical and agrochemical industries, where it can be used as a building block for the synthesis of various bioactive compounds. Additionally, it can also be used as an intermediate for the production of pesticides and herbicides. Methyl 3-hydroxy-1-methylpyrazole-5-carboxylate is known for its stability and high purity, making it a valuable compound in various chemical processes. However, it should be handled and stored with proper safety precautions due to its potential health hazards.

InChI:InChI=1/C6H8N2O3/c1-8-4(6(10)11-2)3-5(9)7-8/h3H,1-2H3,(H,7,9)

Upstream product

• 58364-79-7 2-(1-Methylhydrazino)maleinsaeure-dimethylester 
• 762-42-5 dimethyl acetylenedicarboxylate 
• 60-34-4 methylhydrazine 
• 22038-72-8 methyldiazene 
• 302-15-8 methylhydrazine sulfuric acid 
• 86625-25-4 methyl 3-hydroxy-1H-pyrazole-5-carboxylate 
• 74-88-4 methyl iodide 
• 123-54-6 acetylacetone 
• 542-92-7 cyclopenta-1,3-diene 

Downstream Products

• 692259-01-1 5-(2-biphenyl-4-yl-2-oxoethoxy)-2-methyl-2H-pyrazole-3-carboxylic acid methyl ester 
• 692258-99-4 2-methyl-5-(2-oxo-2-phenylethoxy)-2H-pyrazole-3-carboxylic acid methyl ester 
• 692259-00-0 5-[2-(4-chlorophenyl)-2-oxoethoxy]-2-methyl-2H-pyrazole-3-carboxylic acid methyl ester 
• 692259-06-6 2-methyl-5-(2-oxo-2-phenylethoxy)-2H-pyrazole-3-carboxylic acid 
• 692259-07-7 5-[2-(4-chlorophenyl)-2-oxoethoxy]-2-methyl-2H-pyrazole-3-carboxylic acid 
• 692259-13-5 2-methyl-5-(2-oxo-2-phenylethoxy)-2H-pyrazole-3-carboxylic acid tert-butyl ester 
• 692259-14-6 5-[2-(4-chlorophenyl)-2-oxoethoxy]-2-methyl-2H-pyrazole-3-carboxylic acid tert-butyl ester 
• 692259-27-1 2-methyl-5-(4-methylene-5-oxo-2-phenyl-tetrahydro-furan-2-ylmethoxy)-2H-pyrazole-3-carboxylic acid 
• 692259-15-7 5-(2-biphenyl-4-yl-2-oxoethoxy)-2-methyl-2H-pyrazole-3-carboxylic acid tert-butyl ester 
• 692259-20-4 2-methyl-5-(4-methylene-5-oxo-2-phenyltetrahydrofuran-2-ylmethoxy)-2H-pyrazole-3-carboxylic acid tert-butyl ester 
• 692259-28-2 5-[2-(4-chloro-phenyl)-4-methylene-5-oxo-tetrahydro-furan-2-ylmethoxy]-2-methyl-2H-pyrazole-3-carboxylic acid 
• 692259-21-5 5-[2-(4-chlorophenyl)-4-methylene-5-oxotetrahydrofuran-2-ylmethoxy]-2-methyl-2H-pyrazole-3-carboxylic acid tert-butyl ester 
• 692259-29-3 5-(2-biphenyl-4-yl-4-methylene-5-oxo-tetrahydro-furan-2-ylmethoxy)-2-methyl-2H-pyrazole-3-carboxylic acid 
• 692259-22-6 5-(2-biphenyl-4-yl-4-methylene-5-oxotetrahydrofuran-2-ylmethoxy)-2-methyl-2H-pyrazole-3-carboxylic acid tert-butyl ester 

Relevant articles and documents

BI-ARYL DIHYDROOROTATE DEHYDROGENASE INHIBITORS

Disclosed are compounds, compositions and methods for treating diseases, disorders, or medical conditions that are affected by the modulation of DHODH. Such compounds are represented by Formula I as follows: Formula I wherein R1, R2, R3, and Q are defined herein.

Macrocyclic compound serving as ALK and ROS regulators

The invention belongs to the field of medicinal chemistry, and relates to a macrocyclic compound serving as an ALK and ROS regulators, in particular to a compound as shown in a formula I or pharmaceutically acceptable salt thereof, a preparation method, a

Compound for treatment on hepatitis B and use thereof

The invention relates to a compound for treatment on hepatitis B and a use thereof. Specifically, the invention discloses a compound as a HBV replication inhibitor having the structure shown in the formula (A), or its stereoisomer, tautomer, pharmaceutically acceptable salt, hydrate or solvate. The groups are detailed in the specification. The invention also relates a pharmaceutical composition containing the compound and a use thereof in treatment on hepatitis B.